CUV clinuvel pharmaceuticals limited

Ann: Study confirms NB-UVB needed to activate repigmentation, page-2

  1. 905 Posts.
    lightbulb Created with Sketch. 373
    Price sensitive!! Well done ASX.

    n=3. Only n=1 completed trial.

    the “result” is no surprise, obviously or why are they doing 105 and 107? just why they chose to present the result at all and why at this point in time. They have known this outcome for at least a couple of years. Probably waiting for the statistical analysis to be completed. Maybe Wolgen clearing the decks. Who knows. Weird company.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$11.89
Change
-0.110(0.92%)
Mkt cap ! $595.9M
Open High Low Value Volume
$11.75 $12.24 $11.68 $1.039M 86.69K

Buyers (Bids)

No. Vol. Price($)
1 177 $11.86
 

Sellers (Offers)

Price($) Vol. No.
$12.15 3 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.